173 related articles for article (PubMed ID: 31144996)
1. The Sub-Phenotypes of Sickle Cell Disease in Kuwait.
Adekile AD; Al-Sherida S; Marouf R; Mustafa N; Thomas D
Hemoglobin; 2019 Mar; 43(2):83-87. PubMed ID: 31144996
[TBL] [Abstract][Full Text] [Related]
2. Limitations of Hb F as a phenotypic modifier in sickle cell disease: study of Kuwaiti Arab patients.
Adekile AD
Hemoglobin; 2011; 35(5-6):607-17. PubMed ID: 21999156
[TBL] [Abstract][Full Text] [Related]
3. Hb S (
Azarkeivan A; Cohan N; Niazkar HR; Azizi A; Rad F
Hemoglobin; 2020 Mar; 44(2):109-112. PubMed ID: 32370567
[TBL] [Abstract][Full Text] [Related]
4. Does elevated hemoglobin F modulate the phenotype in Hb SD-Los Angeles?
Adekile A; Mullah-Ali A; Akar NA
Acta Haematol; 2010; 123(3):135-9. PubMed ID: 20110664
[TBL] [Abstract][Full Text] [Related]
5. Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait.
Adekile AD; Gupta R; Yacoub F; Sinan T; Al-Bloushi M; Haider MZ
Acta Haematol; 2001; 105(1):27-31. PubMed ID: 11340250
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin F concentration as a function of age in Kuwaiti sickle cell disease patients.
Adekile A; Al-Kandari M; Haider M; Rajaa M; D'Souza M; Sukumaran J
Med Princ Pract; 2007; 16(4):286-90. PubMed ID: 17541294
[TBL] [Abstract][Full Text] [Related]
7. Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.
Jha AN; Mishra H; Verma HK; Pandey I; Lakkakula BVKS
Hemoglobin; 2018 Mar; 42(2):84-90. PubMed ID: 30200838
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic Diversity of Sickle Cell Disease in Patients with a Double Heterozygosity for Hb S and Hb D-Punjab.
Torres LS; Okumura JV; Belini-Júnior É; Oliveira RG; Nascimento PP; Silva DG; Lobo CL; Oliani SM; Bonini-Domingos CR
Hemoglobin; 2016 Sep; 40(5):356-358. PubMed ID: 27535451
[TBL] [Abstract][Full Text] [Related]
9. Avascular necrosis of the femoral head in adult Kuwaiti sickle cell disease patients.
Marouf R; Gupta R; Haider MZ; Al-Wazzan H; Adekile AD
Acta Haematol; 2003; 110(1):11-5. PubMed ID: 12975550
[TBL] [Abstract][Full Text] [Related]
10. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.
Akar NA; Adekile A
Med Princ Pract; 2008; 17(5):404-8. PubMed ID: 18685282
[TBL] [Abstract][Full Text] [Related]
11. First Report of Compound Heterozygosity for Hb S (
Ogu UO; Reyes Gil M; Tolu SS; Acharya SA; Minniti CP
Hemoglobin; 2021 Mar; 45(2):136-139. PubMed ID: 34134586
[TBL] [Abstract][Full Text] [Related]
12. Silent brain infarcts are rare in Kuwaiti children with sickle cell disease and high Hb F.
Adekile AD; Yacoub F; Gupta R; Sinan T; Haider MZ; Habeeb Y; Al-Bloushi M; Moosa A
Am J Hematol; 2002 Jul; 70(3):228-31. PubMed ID: 12111768
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.
Adekile AD; Azab AF; Al-Sharida SI; Al-Nafisi BA; Akbulut N; Marouf RA; Mustafa NY
Hemoglobin; 2015; 39(5):320-6. PubMed ID: 26076396
[TBL] [Abstract][Full Text] [Related]
14. Pattern of bone mineral density in sickle cell disease patients with the high-Hb F phenotype.
Gupta R; Marouf R; Adekile A
Acta Haematol; 2010; 123(1):64-70. PubMed ID: 19955714
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Effect of Hydroxyurea on Hb F in Sickle Cell Disease: Ten-Year Egyptian Experience.
Youssry I; Abdel-Salam A; Ismail R; Bou-Fakhredin R; Mohamed Samy R; Ezz El-Deen F; Taher AT
Hemoglobin; 2017; 41(4-6):267-273. PubMed ID: 29251012
[TBL] [Abstract][Full Text] [Related]
16. Morbidity, beta S haplotype and alpha-globin gene patterns among sickle cell anemia patients in Kuwait.
Adekile AD; Haider MZ
Acta Haematol; 1996; 96(3):150-4. PubMed ID: 8876612
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
[TBL] [Abstract][Full Text] [Related]
18. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
[TBL] [Abstract][Full Text] [Related]
20. Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study.
Kolliopoulou A; Siamoglou S; John A; Sgourou A; Kourakli A; Symeonidis A; Vlachaki E; Chalkia P; Theodoridou S; Ali BR; Katsila T; Patrinos GP; Papachatzopoulou A
Hemoglobin; 2019 Jan; 43(1):27-33. PubMed ID: 31039620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
